Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...

Whether finding new treatments for schizophrenia or first-time ways to tackle bladder cancer, these companies are finding ...

China: A recent multicenter randomized controlled trial has highlighted the potential benefits of acupuncture as a ...

With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

Many people with COPD have other conditions like diabetes or high cholesterol, too. Managing several conditions can be ...

Altesa BioSciences, Inc., a clinical-stage pharmaceutical company dedicated to developing new treatments for viral infections in vulnerable populations, today announced that the U.S. Food and Drug ...

Dupilumab added to standard COPD triple therapy reduces the annual rate of moderate exacerbations but not severe exacerbations.

Regardless of what's causing the condition, COPD is treatable. "The mainstays of therapy have historically been inhaled bronchodilators and inhaled steroids," says Han. Such medications can reduce ...

Dupilumab vs placebo was linked to improved health-related quality of life and respiratory symptoms in patients with COPD and T2 inflammation.

SGLT2 inhibitors and GLP-1RAs yielded lower risks for COPD exacerbation than DPP-4 inhibitors among patients with type 2 diabetes.